IF by specialty › Rheumatology
Annals of the Rheumatic Diseases — Impact Factor
The 2025 Impact Factor of Annals of the Rheumatic Diseases is 24.0 (Q1 in Rheumatology; subscription or hybrid).
- Impact Factor
- 24.0 JCR 2025
- JCR category
- Rheumatology
- Quartile
- Q1 in Rheumatology
- Publisher
- Elsevier (EULAR)
- Open access
- subscription or hybrid
- Abbreviations
- ARD
- IF source
- ard.eular.org
Position within the field
Ranked 3 of the 33 journals in Rheumatology on this site (top 10%).
Rheumatology journals with a similar Impact Factor
- Nature Reviews Rheumatology IF 33.7
- The Lancet Rheumatology IF 29.5
- Arthritis & Rheumatology IF 9.9
- Osteoarthritis and Cartilage IF 9.2
- Best Practice & Research Clinical Rheumatology IF 7.0
- Arthritis Research & Therapy IF 5.4
About this value
Annals of the Rheumatic Diseases is abbreviated ARD. The Journal Impact Factor of Annals of the Rheumatic Diseases (JCR 2025, released June 2026) is 24.0. Values are compiled by cross-checking figures published by publishers and societies against public aggregators; this is not a reproduction of Clarivate Journal Citation Reports™. Confirm the current value on the publisher's page or in JCR before deciding where to submit. The quartile (Q1–Q4) is the journal's relative position within its JCR category; Q1 means the top 25%.
Last updated September 2026. Report errors via the contact form. Other journals in the same category: Rheumatology.